Efficacy and Safety of Concurrent Radiochemotherapy and Sequential Radiochemotherapy for Rectal Cancer：A Systematic Review
李征,米登海,曹农,杨克虎,田金徽,马彬,拜争刚
DOI: https://doi.org/10.3969/j.issn.1007-9572.2015.32.014
2015-01-01
Chinese General Practice
Abstract:Objective To systematically review the efficacy and safety of different schedules of radiotherapy and chemotherapy for rectal cancer,and to provide references for clinical practice and research. Methods We made computer -based retrieval in foreign databases such as Cochrane Library,PubMed,EMBase,Web of Science and Chinese ones including CBM,CNKI,VIP and Wanfang to collect relevant literatures. Then we made further literature screening to extract primary information including grouping method,gender,age,KPS score,clinical staging and outcome indicators. We compared the differences of overall survival rate,progression - free survival rate,total effective rate,complete remission rate and the incidence of adverse reactions between concurrent radiochemotherapy and sequential radiochemotherapy for patients with rectal cancer. Results Twelve literatures were selected with 1 191 patients included. The results of meta - analysis showed there was no statistically significant difference in 1 - year overall survival rate between the two groups〔 OR = 1. 47,95% CI(0. 96, 2. 26),P ﹥ 0. 05〕. The 2 - year overall survival rate〔OR = 2. 04,95% CI(1. 26,3. 30),P ﹤ 0. 05〕and 3 - year overall survival rate〔OR = 2. 04,95% CI(1. 50,2. 78),P ﹤ 0. 05〕of concurrent schedule group were higher than sequential schedule group. There was no statistically significant difference in 5 - year overall survival rate between the two groups〔OR =1. 30,95% CI(0. 73,2. 33),P ﹥ 0. 05〕. The 1 - year progression - free survival rate〔 OR = 2. 68,95% CI(1. 76, 4. 07),P ﹤ 0. 001〕,2 - year progression - free survival rate〔 OR = 2. 66,95% CI(1. 19,5. 95),P = 0. 02〕,3 - year progression - free survival rate〔OR = 1. 70,95% CI(1. 18,2. 45),P = 0. 004〕and total effective rate〔OR = 2. 49,95%CI(1. 25,4. 97 ),P = 0. 01 〕of concurrent schedule group were higher than sequential schedule group. There was no statistically significant difference in complete remission rate between the two groups(P ﹥ 0. 05). The incidence of diarrhea in concurrent schedule group was higher than sequential schedule group〔 OR = 2. 94,95% CI(1. 88,4. 60),P ﹤ 0. 001〕. There were no statistically significant differences between two groups in the incidence rates of nausea and vomiting,severe decrease of leucocyte and platelets,neurotoxicity,abdominal pain and reaction of skin and mucous membrane(P ﹥ 0. 05). The incidence of acute diarrhea in concurrent schedule group was higher than sequential schedule group〔 OR = 2. 39,95% CI (1. 31,4. 38),P = 0. 005〕. There were no statistically significant differences between two groups in the incidence rates of severe nausea and vomiting,severe decrease of leucocyte and severe neurotoxicity(P ﹥ 0. 05). Conclusion Compared with the sequential radiochemotherapy,concurrent radiochemotherapy can improve overall survival rate and progression - free survival rate of patients with rectal cancer;however,the concurrent scheme has a higher incidence of adverse reactions,especially diarrhea. The two schedules of radiochemotherapy have both advantages and disadvantages.